Key result
Right ventricular dilation with systolic impairment was independently associated with 90-day mortality (OR 3.11) in invasively ventilated patients with COVID-19 ARDS.
Why the study?
Is right ventricular dilation with systolic impairment associated with increased mortality in invasively ventilated patients with COVID-19 ARDS?
Cohort (n=172)
No
Is right ventricular dilation with systolic impairment associated with increased mortality in invasively ventilated patients with COVID-19 ARDS?
Odds Ratio: 3.11 (95% CI 1.15–7.6)
Absolute Event Rate: 72% vs 32%
p-value: p=<0.0001
In patients with COVID-19 ARDS, the combination of right ventricular dilation and systolic impairment is independently associated with increased 90-day mortality.
No takes yet. Share an insight, caveat, or question.
Chotalia et al. (2021) conducted a cohort in COVID-19 acute respiratory distress syndrome (n=172). Right ventricular dilation with systolic impairment vs. Without right ventricular dilation with systolic impairment was evaluated on 90-day mortality (OR 3.11, 95% CI 1.15-7.60, p=<0.0001). Right ventricular dilation with systolic impairment was independently associated with 90-day mortality (OR 3.11) in invasively ventilated patients with COVID-19 ARDS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: